Company / PP&E per Share
Immunovant, Inc. PP&E per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2024
5-year range
$0.00 / $0.00
FY2020-FY2024
Trend
+26.4%
vs FY2023
Sector context
#176 of 193
Health Care
What the data says
Among 193 Health Care companies, Immunovant, Inc. is in the bottom 9% for pp&e per share. PP&E per Share has fluctuated over the past 6 years, ranging from $0.00 in FY2020 to $0.00 in FY2024.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of +19.5%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +18.5%
- 5-Year CAGR
- +19.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 193This company $0.00 Sector average $18.71
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, pp&e per share increased 26.4% year-over-year.
- Ranks #176 out of 193 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | +26.4% |
| FY2023 | $0.00 | -10.1% |
| FY2022 | $0.00 | +46.3% |
| FY2021 | $0.00 | +147.4% |
| FY2020 | $0.00 | -40.7% |
| FY2019 | $0.00 | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026